Výsledky vyhledávání - "Teniente-Serra A"

Akademický článek

VALIDA project: Validation of allergy in vitro diagnostics assays (Tools and recommendations for the assessment of in vitro tests in the diagnosis of allergy)

Autor: Casas María L., Esteban Ángel, González-Muñoz Miguel, Labrador-Horrillo Moisés, Pascal Mariona, Teniente-Serra Aina

Publikováno v: Advances in Laboratory Medicine, Vol 1, Iss 4, Pp 1671-3 (2020)

In vitro allergen-specific immunoglobulin E (IgE) detection and quantification tests are routinely performed in clinical laboratories to diagnose patients with a suspected allergy. Numerous commercial assays are available to test for allergies, but t

Externí odkaz: https://doaj.org/article/fcf8fd10c29740fc995cc3b2d7226d82

Zobrazit plný text záznamu

Akademický článek

Proyecto VALIDA: Validation of ALlergy In vitro Diagnostics Assays (Herramientas y recomendaciones para la valoración de las pruebas in vitro en el diagnóstico de la alergia)

Autor: Casas María L., Esteban Ángel, González-Muñoz Miguel, Labrador-Horrillo Moisés, Pascal Mariona, Teniente-Serra Aina

Publikováno v: Advances in Laboratory Medicine, Vol 1, Iss 4, Pp 1671-3 (2020)

En la evaluación del paciente con sospecha de alergia las pruebas de detección y cuantificación de la inmunoglobulina E (IgE) específica in vitro se usan de manera habitual en los laboratorios clínicos para ayudar en el diagnóstico de la alergi

Externí odkaz: https://doaj.org/article/a27013044259400f8dd6ed9425ee0cb9

Zobrazit plný text záznamu

Akademický článek

Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients

Autor: Cristina López, Nathalie Depreux, Isabel Bielsa, Albert Roger, Bibiana Quirant-Sanchez, Maria Basagaña, Yanina Jurgens, Clara Padró, Sira Miquel, Eva Martinez-Caceres, Aina Teniente-Serra

Publikováno v: Frontiers in Immunology, Vol 15 (2024)

BackgroundChronic spontaneous urticaria (CSU) is a highly prevalent and difficult to manage cutaneous disease characterized by the presence of recurrent urticaria, angioedema, or both, for a period of 6 weeks or longer. One of the biological treatmen

Externí odkaz: https://doaj.org/article/9d988bfbb70b4a6495d0ba11e1dc458d

Zobrazit plný text záznamu

Akademický článek

Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers

Autor: Neus Rabaneda-Lombarte, Aina Teniente-Serra, Anna Massuet-Vilamajó, Cristina Ramo-Tello, Silvia Presas-Rodríguez

Publikováno v: Frontiers in Immunology, Vol 15 (2024)

ObjectiveWe present a case of multiple tumefactive demyelinating lesions (TDLs) emerging 24 months after the second cycle of alemtuzumab treatment.MethodsA woman with relapsing-remitting multiple sclerosis (MS) discontinued fingolimod treatment due t

Externí odkaz: https://doaj.org/article/3586032a62b54b5fbf434b0585fc81aa

Zobrazit plný text záznamu